Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,472
datasets available to search
ShareScore release 0.9.0
Dataset results
1,472 results for “EGFR”
Feasibility of the Research for Mutation of K-ras and EGFR in CTCs From Metastatic Non Small Cells Bronchial Carcinomas
ClinicalTrials.gov study NCT01380795. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Sunvozertinib Plus Anlotinib as 1L Treatment in EGFR-Sensitive Mutations Combined With Co-Mutations Advanced NSCLC
ClinicalTrials.gov study NCT06348927. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant Furmonertinib and Cisplatin/Pemetrexed as in EGFR Mutated Stage IIIA-IIIB Resectable NSCLC (FORESEE)
ClinicalTrials.gov study NCT05430802. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of DBPR112 in Patients With Head and Neck Cancer and EGFR Mutated Lung Cancer
ClinicalTrials.gov study NCT03246854. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of Sintilimab With or Without Radiotherapy in Patients With Recurrent or IV NSCLC (EGFR -, ALK -) After Failure of Platinum-based Chemotherapy: A Randomized,Open Labled, Phase II C
ClinicalTrials.gov study NCT04513301. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study of Prevalence of EGFR Mutations in Participants With NSCLC
ClinicalTrials.gov study NCT02695849. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Mechanisms of Resistance to Amivantamab in Patients With NSCLC With EGFR Exon 20 Insertion
ClinicalTrials.gov study NCT06247826. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Correlation Between EGFR Mutation Using cfDNAs and Circulating Tumor Cells in Patients With NSCLC
ClinicalTrials.gov study NCT02422628. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Nintedanib Plus EGFR TKI In EGFR-mutated Non-small Cell Lung Cancer Patients
ClinicalTrials.gov study NCT06071013. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 1 Study of IMGN289 in Adult Patients With EGFR-positive Solid Tumors
ClinicalTrials.gov study NCT01963715. IPD Sharing: Not stated. Countries: 1. Publications: 0.
To Evaluate the Efficacy of QLH11811 in Advanced NSCLC Patients With EGFR Mutation
ClinicalTrials.gov study NCT05555212. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Toripalimab Therapy After Resection in High-risk Stage IA2-IB NSCLC With no Driver Alterations (EGFR or ALK)
ClinicalTrials.gov study NCT06221670. IPD Sharing: NO. Countries: 1. Publications: 0.
ObservationaL Study on the Qol of RAS Wild-type mCRC Patients Receiving Anti-EGFR MAbs + FOLFOX or FOLFIRI as 1st Line
ClinicalTrials.gov study NCT02624895. IPD Sharing: YES. Countries: 1. Publications: 0.
A Retrospective Study About Treatment Strategy After First/Second Line EGFR-TKI Failure
ClinicalTrials.gov study NCT02618590. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of the Combination of Osimertinib, Platinum and Etoposide for Patients With Metastatic EGFR Mutant Lung Cancers
ClinicalTrials.gov study NCT03567642. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Osimertinib With Stereotactic Radiosurgery (SRS) in Brain Metastases From EGFR Positive NSCLC
ClinicalTrials.gov study NCT03535363. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Almonertinib Therapy in Patients With Abnormal Liver Function After EGFR-TKI Treatment, or Almonertinib First-line Therapy in Patients With Basic Hepatopathy
ClinicalTrials.gov study NCT05662813. IPD Sharing: NO. Countries: 1. Publications: 0.
Real-world Study of Sunvozertinib Treatment in Advanced EGFR-Mutant NSCLC After EGFR-TKI Treatment Failure
ClinicalTrials.gov study NCT06786208. IPD Sharing: NO. Countries: 1. Publications: 0.
Erlotinib Treatment Beyond Progression in EGFR Mutant NSCLC
ClinicalTrials.gov study NCT02064491. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of ONO-7475 in Combination With Osimertinib in EGFR Gene Mutation-positive Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT06525246. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.